ESR1 promoter hypermethylation does not predict atypia in RPFNA nor persistent atypia after 12 months tamoxifen chemoprevention

Julie H. Ostrander, Joseph C. Baker, Siya Lem, Gloria Broadwater, Gregory R. Bean, Nicholas C. D'Amato, Vanessa K. Goldenberg, Craig Rowell, Catherine Ibarra-Drendall, Tracey Grant, Patrick G. Pilie, Shauna N. Vasilatos, Michelle M. Troch, Victoria Scott, Lee G. Wilke, Carolyn Paisie, Sarah M. Rabiner, Alejandro Torres-Hernandez, Carola M. Zalles, Victoria L. Seewaldt